VF
KAPA

Virtu Financial’s Kairos Pharma KAPA Stock Holding History

Virtu Financial’s Portfolio KAPA Stock Details KAPA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31K Buy
+11,727
New +$42.6K ﹤0.01% 1296
2026
Q1 		– Sell
-2,897
Closed -$14K – 2446
2025
Q4 		$14K Buy
+2,897
New +$19K ﹤0.01% 1479
2025
Q1 		– Sell
-1,951
Closed -$21K – 2179
2024
Q4 		$21K Sell
1,951
-2,722
-58% -$29.2K ﹤0.01% 1293
2024
Q3 		$51K Buy
+4,673
New +$66.8K ﹤0.01% 1010

Other funds holding KAPA

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
SFG
SevenBridge Financial Group Harrisburg, Pennsylvania $680M AUM 30.75% 1-Year Est. Return
ACA
Aptus Capital Advisors Fairhope, Alabama $14.6B AUM 22.78% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Virtu Financial's KAPA Position: Q2 2026 in Review

Virtu Financial opened a new position in Kairos Pharma (KAPA) in Q2 2026: 11,727 shares worth $31K. The stake represents ﹤0.01% of the portfolio and ranks #1296 among its holdings. This is a return to the name: Virtu Financial previously reported a position in KAPA as recently as Q4 2025.

Virtu Financial first reported a position in KAPA in Q3 2024 and has held it in 4 quarters since. The position peaked at $51K in Q3 2024. 14 funds tracked by Wall St. Rank hold KAPA as of Q2 2026.

  • Virtu Financial held 11,727 shares of Kairos Pharma worth $31K as of Q2 2026.
  • Kairos Pharma was a new Virtu Financial position in Q2 2026.
  • Kairos Pharma made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1296 holding.
  • Virtu Financial first reported a position in Kairos Pharma in Q3 2024 and has held it in 4 quarters since.
  • Virtu Financial's Kairos Pharma position peaked at $51K in Q3 2024.
  • 14 funds tracked by Wall St. Rank held Kairos Pharma as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.